
- #Amdocs actix full#
- #Amdocs actix free#
Net income on a non-GAAP basis was $103.4 million, or $0.63 per diluted share, compared to non-GAAP net income of $115.7 million, or $0.70 per diluted share, in the fourth quarter of fiscal 2012. Expected non-GAAP diluted earnings per share growth of roughly 6-9%, which incorporates modest accretion from the combined impact of Actix and Celcite and the impact of anticipated share repurchase activity over the course of the fiscal yearĪmdocs Limited (NYSE: DOX) today reported that for its fiscal quarter ended September 30, 2013, revenue was $845.2 million, up 0.5% sequentially from the third fiscal quarter of 2013 and up 2.8% as compared to last year's fourth fiscal quarter.
Fiscal 2014 guidance: Expected revenue growth of 4-8%, which incorporates an organic growth outlook of roughly 2-5% and an aggregate expected contribution from Actix and Celcite of approximately 2-3%. Expected diluted GAAP EPS of approximately $0.58-$0.66 Expected diluted non-GAAP EPS of approximately $0.72-$0.78, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.06-$0.07 per share of equity-based compensation expense, net of related tax effects. #Amdocs actix full#
First quarter fiscal 2014 guidance: Expected revenue of approximately $845-$875 million which includes the consolidation of Actix for the full quarter but does not incorporate any contribution from Celcite as the deal may not close within the quarter. The board of directors approved a $0.13 per share quarterly cash dividend to be paid on January 17, 2014, and approved an increase in the quarterly cash dividend to $0.155 per share to be paid on April 17, 2014, subject to shareholder approval. Repurchased $97 million of ordinary shares during the fourth fiscal quarter. Twelve-month backlog of $2.87 billion at the end of the fourth fiscal quarter, up $40 million from the end of the third quarter of fiscal 2013. #Amdocs actix free#
Free cash flow of $205 million for the fourth fiscal quarter. Diluted GAAP EPS of $0.54 for the fourth fiscal quarter, within the $0.50-$0.58 guidance range. Fourth fiscal quarter diluted non-GAAP EPS of $0.63, within the $0.60-$0.66 guidance range, excluding amortization of purchased intangible assets and other acquisition related costs and equity-based compensation expense, net of related tax effects. Fourth fiscal quarter non-GAAP operating income of $141 million non-GAAP operating margin of 16.7% GAAP operating income of $123 million. Foreign currency movements had a negligible effect on revenue relative to the third quarter of fiscal 2013 Fourth fiscal quarter revenue of $845 million, within the $830-$860 million guidance range. Closed acquisition of Actix on September 19, 2013 Additional consideration may be paid later based on the achievement of certain performance metrics. Signed definitive agreement to acquire Celcite Management Solutions, LLC for approximately $129 million in cash, subject to customary closing conditions.